Oramed Pharmaceuticals
ORMP
$2.30
Share price
-1.29%
Change (1 day)
-36.64%
Change (1 year)
Categories
EPS for Oramed Pharmaceuticals (ORMP)
EPS in 2023 (TTM): -$0.51
According to Oramed Pharmaceuticals's latest financial reports the company's current EPS (TTM) is -$0.51. In 2022 the company made an earnings per share (EPS) of -$0.94 a decrease over its 2021 EPS that were of -$0.77.
EPS history for Oramed Pharmaceuticals from 2006 to 2023
Annual EPS
| Year | EPS | Change |
|---|---|---|
| 2023 (TTM) | -$0.51 | -45.74% |
| 2022 | -$0.94 | 22.08% |
| 2021 | -$0.77 | 16.67% |
| 2020 | -$0.66 | -8.33% |
| 2019 | -$0.72 | -22.58% |
| 2018 | -$0.93 | 20.78% |
| 2017 | -$0.77 | -10.47% |
| 2016 | -$0.86 | 22.86% |
| 2015 | -$0.70 | 6.06% |
| 2014 | -$0.66 | 13.79% |
| 2013 | -$0.58 | -7.94% |
| 2012 | -$0.63 | |
| 2011 | N/A | -100% |
| 2010 | -$0.60 | 25% |
| 2009 | -$0.48 | -50% |
| 2008 | -$0.96 | -11.11% |
| 2007 | -$1.08 | 668.73% |
| 2006 | -$0.14 |
EPS for similar companies or competitors
| Company | EPS | EPS differencediff. | Country |
|---|---|---|---|
 Novo Nordisk NVO | $2.86 | -659.95% | 🇩🇰 Denmark |
 Sanofi SNY | $3.18 | -723.58% | 🇫🇷 France |
 Ultragenyx RARE | -$10.24 | 1,907.84% | 🇺🇸 USA |
 Lexicon Pharmaceuticals
LXRX | -$0.68 | 33.33% | 🇺🇸 USA |
 Compugen CGEN | -$0.40 | -21.57% | 🇮🇱 Israel |